pargyline has been researched along with sincalide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, S; Katsuura, G | 2 |
| Fink, H; Marsden, CA; Morgenstern, R; Reum, T; Schäfer, U | 1 |
| Fink, H; Marsden, CA; Morgenstern, R; Reum, T | 1 |
4 other study(ies) available for pargyline and sincalide
| Article | Year |
|---|---|
Suppressive action of cholecystokinin octapeptide on the behavioral effects of L-DOPA in the rat.
Topics: Animals; Behavior, Animal; Cholecystokinin; Levodopa; Male; Motor Activity; Pargyline; Peptide Fragments; Rats; Rats, Inbred Strains; Sincalide; Thyrotropin-Releasing Hormone | 1981 |
Effect of cholecystokinin on thyrotropin releasing hormone (TRH)-induced serotonin potentiation in rats.
Topics: 5-Hydroxytryptophan; Animals; Cholecystokinin; Drug Synergism; Male; Pargyline; Peptide Fragments; Rats; Rats, Inbred Strains; Serotonin; Sincalide; Thyrotropin-Releasing Hormone | 1982 |
Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Extracellular Space; Hormone Antagonists; Male; Microinjections; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Pargyline; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Tetragastrin; Ventral Tegmental Area | 1997 |
Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry.
Topics: Anesthesia; Animals; Apomorphine; Brain Chemistry; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Electrophysiology; Extracellular Space; Male; Microinjections; Monoamine Oxidase Inhibitors; Nootropic Agents; Nucleus Accumbens; Pargyline; Rats; Rats, Wistar; Sincalide; Ventral Tegmental Area | 1998 |